Curis (CRIS) Amortizatization of Intangibles (2010 - 2024)
Curis (CRIS) reported Amortizatization of Intangibles of -$428000.0 for Q4 2024, down 2953.33% on a YoY basis from $15000.0 in Q1 2024, and down 7033.33% quarter-over-quarter from -$6000.0 in Q3 2024.
Curis (CRIS) Amortizatization of Intangibles (2010 - 2024) Analysis & Trends
Curis has reported Amortizatization of Intangibles for 15 years, with the latest figure at -$428000.0 in Q4 2024.
- For the quarter ending Q4 2024, Amortizatization of Intangibles fell 2953.33% year-over-year to -$428000.0; the trailing twelve-month figure through Sep 2025 stood at -$428000.0 (down 193.25% YoY), and the FY2024 full-year result was $16000.0, down 98.49% from the prior year.
- Amortizatization of Intangibles for Q4 2024 stood at -$428000.0, down from -$6000.0 in the prior quarter.
- The five-year high for Amortizatization of Intangibles was $534000.0 in Q2 2024, with the low at -$439000.0 in Q2 2021.
- Historically, Amortizatization of Intangibles has averaged -$35550.0 across 5 years, with a median of -$15500.0 in 2020.
- Annual changes were most pronounced in 2021 — Amortizatization of Intangibles tumbled 19550.0% — and 2023, when it soared 681.58%.
- Curis' Amortizatization of Intangibles stood at $2000.0 in 2020, then plunged by 19550.0% to -$389000.0 in 2021, then soared by 177.12% to $300000.0 in 2022, then tumbled by 95.0% to $15000.0 in 2023, then sank by 2953.33% to -$428000.0 in 2024.
- The last three Amortizatization of Intangibles figures came in at -$428000.0 (Q4 2024), -$6000.0 (Q3 2024), and $534000.0 (Q2 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | 13,267.00 |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | - |
| 10 | Curis | 8.27 Mn | -6.73 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -428,000.00 |
| Dec 31, 2024 | -428,000.00 |
| Sep 30, 2024 | -6,000.00 |
| Sep 30, 2024 | -6,000.00 |
| Jun 30, 2024 | 534,000.00 |
| Jun 30, 2024 | 534,000.00 |
| Mar 31, 2024 | -84,000.00 |
| Mar 31, 2024 | -84,000.00 |
| Dec 31, 2023 | 15,000.00 |
| Dec 31, 2023 | 15,000.00 |
| Sep 30, 2023 | 442,000.00 |
| Sep 30, 2023 | 442,000.00 |
| Jun 30, 2023 | 457,000.00 |
| Jun 30, 2023 | 457,000.00 |
| Mar 31, 2023 | 145,000.00 |
| Mar 31, 2023 | 145,000.00 |
| Dec 31, 2022 | 300,000.00 |
| Dec 31, 2022 | 300,000.00 |
| Sep 30, 2022 | -76,000.00 |
| Sep 30, 2022 | -76,000.00 |